Recently Sattari et al. 35 found MIAT upregulation in leukemia/lymphoma lymphoid lineage with mature B-cell phenotype; interestingly, they demonstrated a higher incidence of MIAT upregulation in aggressive types of CLL and worst clinical outcome. The gene discussed is MIAT; the disease is B-cell chronic lymphocytic leukemia.